Clinical Trial Update: The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials of the SAINT Neuromodulation System for Major depressive disorder have been terminated, including consideration of suicidal ideation.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SAINT Neuromodulation System

Snippet

Sponsor: Magnus Medical | Conditions: Major Depressive Disorder, Major Depressive Episode | Phase 2, Phase 3 | Status: TERMINATED